logo

Epix Pharmaceuticals, Inc. (EPIX)



Trade EPIX now with
  Date
  Headline
9/14/2020 7:15:34 AM ESSA Pharma: FDA Grants Fast Track Designation To EPI-7386 For Metastatic Castration-Resistant Prostate Cancer
8/6/2020 8:52:54 PM ESSA Pharma Q3 Net Loss Of $4.9 Mln Or $0.24/shr Vs. Net Loss Of $3.3 Mln Or $0.52/shr Prior Year
7/31/2020 10:17:48 AM ESSA Pharma Completes Public Offering For Aggregate Gross Proceeds Of US$48.99 Mln
7/28/2020 9:50:32 PM ESSA Pharma Announces Pricing Of Underwritten Public Offering Of 7.10 Mln Shares At US$6.00/shr
7/15/2020 7:09:07 AM ESSA Pharma Announces First Patient Dosed In A Phase 1 Clinical Trial Of EPI-7386 For MCRPC
6/22/2020 7:35:10 AM ESSA Pharma Presents Therapeutic Potential Of EPI-7386 At 2020 AACR
5/15/2020 7:31:48 AM ESSA Pharma Presents Therapeutic Potential Of EPI-7386 At 2020 Virtual AUA Annual Meeting
3/31/2020 7:06:31 AM ESSA Pharma Submits IND For EPI-7386 For Prostate Cancer; Provides Business Update
10/28/2019 7:36:55 AM ESSA Pharma Presents Data On EPI-7386 At AACR-NCI-EORTC International Conference
8/27/2019 9:25:32 AM ESSA Pharma Completes Public Offering And Concurrent Private Placement For Aggregate $36 Mln
8/14/2019 7:54:24 AM ESSA Pharma Q3 Net Loss $3.3 Mln Or $0.52/Shr Vs Loss Of $2.9 Mln Or $0.50/Shr Last Year
5/10/2019 7:39:50 AM ESSA Pharma Q2 Net Loss $3.4 Mln Or $0.54/Shr Vs Loss $4.4 Mln Or $0.83/Shr Last Year
12/13/2018 5:11:26 PM ESSA Pharma Q4 Loss/share $0.39 Vs. Loss $1.34 Year Ago